Prana Completes Recruitment in Huntington Trial

[at noodls] – 6 month Phase II study with PBT2 in Huntington patients Melbourne – 19 December, 2012: Prana Biotechnology (NASDAQ:PRAN; ASX:PBT) today announced that it has completed recruitment in the Reach2HD Phase … more

View todays social media effects on PRAN

View the latest stocks trending across Twitter. Click to view dashboard

See who Prana is hiring next, click here to view